Tobacco Withdrawal Liquid
NDC Package 55714-4732-1
Package Information
Tobacco Withdrawal (arsenicum alb., benzoicum acidum, berber. vulg., bryonia, caladium seguinum, cantharis, ceanothus, chelidonium majus, chionanthus virginica, cinchona, daphne indica, ignatia, iris versicolor, lycopodium, nicotinum, nux vom., rhus toxicodendron, scutellaria lateriflora, tabacum, echinacea, taraxacum, valeriana) liquids is formulated for associated symptoms such as anxiety, cravings, irritability, stress, cough, excess mucus and headaches. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4732.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 15 [hp_X]/mL
- BENZOIC ACID 15 [hp_X]/mL
- BERBERIS VULGARIS ROOT BARK 15 [hp_X]/mL
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CEANOTHUS AMERICANUS LEAF 15 [hp_X]/mL
- CHELIDONIUM MAJUS 15 [hp_X]/mL
- CHIONANTHUS VIRGINICUS BARK 15 [hp_X]/mL
- CINCHONA OFFICINALIS BARK 15 [hp_X]/mL
- DAPHNE ODORA BARK 15 [hp_X]/mL
- DIEFFENBACHIA SEGUINE 15 [hp_X]/mL
- ECHINACEA, UNSPECIFIED 6 [hp_X]/mL
- IRIS VERSICOLOR ROOT 15 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/mL
- LYTTA VESICATORIA 15 [hp_X]/mL
- NICOTINE 15 [hp_X]/mL
- SCUTELLARIA LATERIFLORA WHOLE 15 [hp_X]/mL
- STRYCHNOS IGNATII SEED 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- TARAXACUM OFFICINALE 6 [hp_X]/mL
- TOBACCO LEAF 15 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 15 [hp_X]/mL
- VALERIAN 6 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Ammonium Ion Binding Activity - [MoA] (Mechanism of Action)
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Cholinergic Nicotinic Agonist - [EPC] (Established Pharmacologic Class)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Nicotine - [CS]
- Nitrogen Binding Agent - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4732 - Tobacco Withdrawal
- 55714-4732-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4732 - Tobacco Withdrawal
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4732-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Tobacco Withdrawal, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains arsenic trioxide; benzoic acid; berberis vulgaris root bark; bryonia alba root; ceanothus americanus leaf; chelidonium majus; chionanthus virginicus bark; cinchona officinalis bark; daphne odora bark; dieffenbachia seguine; echinacea, unspecified; iris versicolor root; lycopodium clavatum spore; lytta vesicatoria; nicotine; scutellaria lateriflora whole; strychnos ignatii seed; strychnos nux-vomica seed; taraxacum officinale; tobacco leaf; toxicodendron pubescens leaf; valerian as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 02, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714473201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.